CARE OF CADAVERIC ORGAN DONORS
Potential cadaveric donors are previously healthy or relatively
healthy people who have experienced brain death and do not have an extracranial malignancy
or untreatable infection. Less than 5% of deaths satisfy these criteria, and only
10% to 20% of these eligible subjects actually become organ donors. In addition,
a significant proportion of potential organ donors are lost to either medical failure
or an inability to obtain consent for donation.[10]
[11]
Significant ethical conflicts surrounding
the
definition of brain death in different social and cultural constructs had been an
obstacle in transplantation.[12]
[13]
[14]
In the United States and Western Europe, a
consensus has been achieved among the scientific community with regard to the definition
of brain death. However, there is and will continue to be considerable discussion
about concepts and definitions of death and the legal definition of death.[15]
Furthermore, these issues are colored by the effects of cultural differences; concepts
and definitions of death are not easily transferred from one culture to another.
Many Western cultures have committed to cadaveric organ donation, and the emphasis
of discussion is quite different from that in Japan or Taiwan, for example.
Determination and Declaration of Brain Death (also
see Chapter 79
)
Worldwide, there is uniform agreement on the neurologic examination
of adult brain-dead subjects, with the
exception of the apnea test. However, standardization of the procedures for diagnosing
brain death is quite different among countries.[16]
Criteria promulgated by the American Academy of Neurology in 1995 are generally
applied in North, Central, and South America.[16]
[17]
These criteria grew out of the landmark Harvard
criteria published in 1968.[17]
In Europe, criteria
for the clinical evaluation of brain death are also fairly uniform, with the principal
difference being the number of physicians needed to confirm the diagnosis. Several
criteria have to be fulfilled to declare brain death. At the time of examination,
the patient must be comatose with neither spontaneous movement nor response to painful
stimuli. A lack of brainstem activity should be confirmed by assessment of the brainstem
and the apnea test ( Table 56-1
).
Possible causes of reversible cerebral dysfunction should be excluded (e.g., hypothermia,
residual drug effects). For the apnea test, the patient is preoxygenated with 100%
oxygen for 10 minutes, PCO2
is confirmed
to be in the normal range (35 to 45 mm Hg), and the patient is administered 100%
oxygen for 10 minutes. Subsequently, the patient is disconnected from the ventilator,
and blow-by oxygen is administered with a T-piece. After 7 to 10 minutes, blood
is drawn for arterial blood gas measurement. A PCO2
value greater than 60 mm Hg confirms lack of brainstem control of ventilation and
represents a positive apnea test. No signs of spontaneous respiratory effort should
be observed during this procedure. Confirmatory tests such as transcranial Doppler,
electroencephalography, and auditory evoked potentials may also be used.